Pharmaceutical company Johnson & Johnson announced Monday that it had agreed to a $5.5 billion settlement following over 10 years of litigation in response to lawsuits claiming its talc products, including baby powder, caused ovarian cancer.
The company will make a $3 billion payment in 2027, with additional payments set for 2028, according to an official Johnson & Johnson press release. Ninety-five percent of the claimants must accept the deal for it to be finalized. The settlement covers 76,000 claims, the company said.
Johnson & Johnson’s Worldwide Vice President of Litigation, Erik Haas, described the settlement as the end of a “meritless 15-year litigation,” according to the same press release.
“The Court’s order placed plaintiffs in an untenable position of having to present specific causation evidence to maintain their claims that does [sic] not exist. While we are…




